Cargando…
Efficacy and Safety of Bone Marrow Cell Transplantation for Chronic Ischemic Heart Disease: A Meta-Analysis
BACKGROUND: Although bone marrow-derived cells (BMCs) have shown great therapeutic potential in patients with chronic ischemic heart disease (CIHD), the exact efficacy and safety of BMCs therapy is still not completely defined. MATERIAL/METHODS: We searched PubMed, OVID, EMBASE, the Cochrane Library...
Autores principales: | Xiao, Chun, Zhou, Shijie, Liu, Yueqiang, Hu, Huozhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199404/ https://www.ncbi.nlm.nih.gov/pubmed/25270584 http://dx.doi.org/10.12659/MSM.892047 |
Ejemplares similares
-
Transendocardial, autologous bone-marrow cell transplant in severe, chronic ischemic heart failure
por: Dohman, HF, et al.
Publicado: (2003) -
Effectiveness and Safety of Autologous Bone Marrow Stromal Cells Transplantation After Ischemic Stroke: A Meta-Analysis
por: Cao, Wenying, et al.
Publicado: (2015) -
Current Opinion of Bone Marrow Stromal Cell Transplantation for Ischemic Stroke
por: KURODA, Satoshi
Publicado: (2016) -
Immediate and short-term safety of catheter-based autologous bone marrow-derived mononuclear cell transplantation into myocardium of patients with severe ischemic heart failure
por: Dohmann, HF, et al.
Publicado: (2003) -
Safety and efficacy of bone marrow-derived cells therapy on cardiomyopathy: a meta-analysis
por: Wang, Chao, et al.
Publicado: (2019)